Nivolumab (nivo) in sorafenib (sor)-naive and -experienced pts with advanced hepatocellular carcinoma (HCC): CheckMate 040 study.

Crocenzi, TS; El-Khoueiry, AB; Yau, TC; Melero, I; Sangro, B; Kudo, M; Hsu, C; Trojan, J; Kim, TY; Choo, SP; Meyer, T; Kang, YK; Yeo, W; Chopra, A; Baakili, A; Dela Cruz, CM; Lang, LX; Neely, J; Welling, T

JOURNAL OF CLINICAL ONCOLOGY, 2017; 35 ( ):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索